Overview

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

Status:
Completed

Trial end date:
2005-05-01

Target enrollment:

Participant gender:

Summary

To assess the efficacy and safety of Alefacept compared to placebo for the treatment of Chronic Plaque Psoriasis in patients for whom conventional therapies are ineffective and inappropriate

Phase:

Phase 3

Details

Lead Sponsor:

Astellas Pharma Inc

Collaborator:

Biogen

Treatments:

Alefacept